[Safety and immunogenicity analysis of recombinant (hansenula polymorpha) hepatitis B vaccine (CpG ODN adjuvant) among adults: the preliminary results of phase I clinical trial]

[Safety and immunogenicity analysis of recombinant (hansenula polymorpha) hepatitis B vaccine (CpG ODN adjuvant) among adults: the preliminary results of phase I clinical trial]

Liang ZZ;Shao Y;Wang SY;Yan CF;Chen B;Zhang J;Chen YP;Hu XS;Lyu HK;;
zhonghua yu fang yi xue za zhi [chinese journal of preventive medicine] 2020 Vol. 54 pp. -
312
zz2020zhonghua[safety

Abstract

Objective: To evaluate the safety and immune effect of recombinant hepatitis B vaccine (CpG ODN adjuvant). Methods: On Oct. 26, 2016, we launched volunteer recruitment in Kaihua county, Quzhou city, Zhejiang Province. In the randomized, double-blind, controlled trial, a total of 48 sub …

Citation

ID: 116827
Ref Key: zz2020zhonghua[safety
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
116827
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet